T2 BIOSYSTEMS INC (TTOO)

US89853L3024 - Common Stock

4.61  -0.08 (-1.71%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

T2 BIOSYSTEMS INC

NASDAQ:TTOO (6/12/2024, 10:31:45 AM)

4.61

-0.08 (-1.71%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS SubIndustry
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%
Sales Q2Q%
CRS
6 Month24.73%
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap70.86M
Shares
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

TTOO Daily chart

Company Profile

T2 Biosystems Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Lexington, Massachusetts and currently employs 158 full-time employees. The company went IPO on 2014-08-07. T2 Biosystems, Inc. is an in-vitro diagnostics company. The firm is focused on the detection of sepsis-causing pathogens and antibiotic resistance genes. The firm is using its T2MR technology, which enables rapid detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum and urine, and can detect cellular targets at limits of detection as low as one colony forming unit per milliliter (CFU/mL). Its primary commercial products include the T2Candida Panel and the T2Bacteria Panel. Its T2Candida Panel is a direct-from-blood test that identifies the lethal form of common bloodstream infections that cause sepsis and candidemia. Its T2Bacteria Panel is a direct-from-blood test that detects certain bacterial pathogens associated with sepsis. Its primary commercial products also include the T2Dx Instrument, the T2Resistance Panel, and the T2SARS-CoV-2 Panel.

Company Info

T2 BIOSYSTEMS INC

101 Hartwell Ave

Lexington MASSACHUSETTS 02421

P: 17814571200

CEO: John Sperzel

Employees: 158

Website: https://www.t2biosystems.com/

TTOO News

News Image21 days ago - T2 Biosystems, Inc.T2 Biosystems Regains Compliance with Nasdaq Continued Listing Requirements

LEXINGTON, Mass., May 22, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing...

News Image26 days ago - T2 Biosystems, Inc.T2 Biosystems Announces Closing of $8 Million Private Placement Priced At-The-Market Under Nasdaq Rules

LEXINGTON, Mass., May 17, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and...

News Imagea month ago - T2 Biosystems, Inc.T2 Biosystems Announces CRG’s Conversion from Preferred Stock to Common Stock

LEXINGTON, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing...

News Imagea month ago - T2 Biosystems, Inc.T2 Biosystems Announces Letter of Intent to Enter Strategic Partnership for Lyme Disease

Advances plan to launch T2Lyme Panel for detection of early Lyme disease...

News Imagea month ago - InvestorPlaceTTOO Stock Earnings: T2 Biosystems Misses EPS, Beats Revenue for Q1 2024

TTOO stock results show that T2 Biosystems missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

News Imagea month ago - BusinessInsiderTTOO Stock Earnings: T2 Biosystems Misses EPS, Beats Revenue for Q1 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips T2 Biosystems (NASDAQ:TTOO) just reported results for the first quarter of 2024...

TTOO Twits

Here you can normally see the latest stock twits on TTOO, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example